Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
multiple sclerosis/tyrosine
Il collegamento viene salvato negli appunti
10 risultati
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168 (PERSEUS)
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Study duration will vary per participant in this event driven trial with a treatment duration of approximately 24 to 48 months.
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Study duration will vary per participant in this event driven trial with a treatment duration of approximately 24 to 48 months.
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Study duration will vary per participant in this event driven trial with a treatment duration of approximately 18 to 36 months.
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Study duration will vary per participant in this event driven trial with a treatment duration of approximately 18 to 36 months.
Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Test plan overview Project phase Phase II
Indication:
Complementary treatment of COVID 19
The purpose of the study:
Examine the efficacy and tolerance of a chlorine dioxide based preparation
Study design:
Quasi-experimental clinical case study
Number of patients expected:
20 patients.
Main inclusion
Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL
Solo gli utenti registrati possono tradurre articoli
Entra registrati
This is a phase I clinical trial to evaluate the safety, tolerability, and maximum tolerated dose of DMF in patients with chronic lymphocytic leukemia. Patients with relapsed/refractory CLL not amenable to available therapies are eligible. This patient population is in need of novel therapies,
Assessing Induction of Type II (M2) Monocytes/Macrophages in Patients Receiving Gilenya.
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Masitinib is a selective tyrosine kinase inhibitor that is thought to exert a neuroprotective effect through its activity on mast cells and other non-neuronal cells of the central nervous system, with subsequent modulation of inflammatory and neurodegenerative processes. The objective of this study
The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The immune and clinical impacts of vitamin D in patients with chronic musculo-skeletal pain
Background Vitamin D is a group of fat-soluble secosteroids, the two major physiologically relevant forms are vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Vitamin D without a subscript refers
A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms
Solo gli utenti registrati possono tradurre articoli
Entra registrati
Chronic myeloid neoplasms (CMPN) consists of three main entities, polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF). These three disorders have many overlapping clinical features. The diseases are clonal stem cell disorders characterized by a chronic excess
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
